Gastrointestinal symptoms and permeability in patients with juvenile idiopathic arthritis

Clinical and Experimental Rheumatology

Volumn 21, Issue 5, 2003, Pages 657-662

  Weber, Peter ^a   Brune, Thomas ^b   Ganser, Gerd ^c   Zimmer, Klaus Peter ^b  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c Northwest German Center for Rheumatology   (Germany)

Author keywords

Faecal 1 antitrypsin level; Gastrointestinal involvement; Intestinal and gastric permeability; Juvenile idiopathic arthritis; Nonsteroidal anti inflammatory drugs

Indexed keywords

ALBUMIN; ALPHA 1 ANTITRYPSIN; ANTIRHEUMATIC AGENT; AZATHIOPRINE; IBUPROFEN; INDOMETACIN; LACTULOSE; MANNITOL; METHOTREXATE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID; SUCROSE; SUGAR;

ABDOMINAL PAIN; ADOLESCENT; ARTICLE; CHRONIC PAIN; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC PROCEDURE; EXCRETION; FECES ANALYSIS; FEMALE; GASTROINTESTINAL ABSORPTION; GASTROINTESTINAL DISEASE; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; IDIOPATHIC DISEASE; INCIDENCE; INTESTINE INJURY; INTESTINE MUCOSA; INTESTINE MUCOSA PERMEABILITY; JUVENILE RHEUMATOID ARTHRITIS; LABORATORY TEST; MALE; OCCULT BLOOD TEST; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN DEPLETION; RISK FACTOR; SCHOOL CHILD; SEROLOGY; STOMACH LESION;

ABDOMINAL PAIN; ADOLESCENT; ALBUMINS; ALPHA 1-ANTITRYPSIN; ANTIBODIES, BACTERIAL; ARTHRITIS, JUVENILE RHEUMATOID; CHILD; DIGESTIVE SYSTEM; FECES; FEMALE; HELICOBACTER PYLORI; HUMANS; LACTULOSE; MALE; MANNITOL; PERMEABILITY; PROSPECTIVE STUDIES; SUCROSE;

EID: 0141987775     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. LIONETTI P, PUPI A, VELTRONI M et al.: Evidence of subclinical intestinal inflammation by 99m technetium leokocyte scintigraphy in patients with HLA-B27 positive juvenile onset active spondyloarthropathy. J Rheumatol 2000; 27: 1538-41.
2. WEBER P, NIESSE G, GANSER G, ZIMMER KP: Body complaints and neuroticism in pediatric rheumatic disease. Klinische Pädiatrie 2001; 213: 17-20.
3. WOLFE MM, LICHTENSTEIN DR, SINGH G: Gastrointestinal toxicity of non-steroidal anti-inflammatory drugs. N Engl J Med 1999; 340: 1888-99.
4. PETTY RE, SOUTHWOOD TR, BAUM J et al.: Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban 1997. J Rheumatol 1998; 25: 1991-4.
5. BRÄHLER E: Giessener Beschwerdebogen für Kinder und Jugendliche Huber, Göttingen 1992.
6. ALLISON JE, TEKAWA IS, RANSOM LJ, ADRAIN AL: A comparison of fecal occult-blood tests for colorectal-cancer screening. N Engl J Med 1996; 334: 155-9.
7. ROBINSON MHE, THOMAS WM, BOSTOCK K, PARKER M, HARDCASTLE JD: Population screening for colorectal carcinoma using a faecal albumin test. Gut 1992; 33: 206 (Suppl.).
8. SUTHERLAND LR, VERHOEF M, WALLACE JL, ROSENDAAL G van, CRUTCHER R, MEDDINGS JB: A simple, non-invasive marker of gastric damage: sucrose permeability. Lancet 1994; 343: 998-1000.
9. ELBURG RM van, UIL JJ, MONCHY JGR de, HEYMANS HSA: Intestinal permeability in pediatric gastroenterology. Scand J Gastroenterol 1992; 27 (Suppl.): 19-24.
10. JANSEN G, MUSKIET FAJ, SCHIERBEEK H, BERGER R, SLIK W van der: Capillary gas chromatographic profiling of urinary, plasma and erythrocyte sugars and polyols as their trimethylsilyl derivatives, preceded by a simple and rapid pre-purification method. Clinica Chimica Acta 1986; 157: 277-94.
11. CATASSI C, BONUCCI A, COPPA GV, CARLUCCI A, GIORGI PL: Intestinal permeability changes during the first month: effect of natural versus artificial feeding. J Ped Gastroenterol Nutrition 1995; 21: 383-6.
12. WILLEMS D, CADRANEL S, JACOBS W: Measurement of urinary sugars by HPLC in the estimation of intestinal permeability: Evaluation in pediatric clinical practice. Clin Chem 1993; 39: 888-90.
13. PORZIO V, BIASI G, CORRADO A et al.: Intestinal histological and ultrastructural inflammatory changes in spondyloarthropathy and rheumatoid arthritis. Scand J Rheumatol 1997; 26: 92-8.
14. MARTINEZ-GONZALEZ O, CANTERO-HINOJOSA J, PAULE-SASTRE P, GOMEZ-MAGAN JC, SALVATIERRA-RIOS D: Intestinal permeability in patients with ankylosing spondylitis and their healthy relatives. Br J Rheumatol 1994; 33: 644-7.
15. BOYLE JT: Chronic abdominal pain. In WALKER WA, DURIE PR, HAMILTON JR, WALKER-SMITH JA and WATKINS JB (Eds.): Pediatric Gastrointestinal Disease. Decker, Philadelphia 1991, 45-54.
16. DOWD JE, CIMAZ R, FINK C: Non-steroidal antiinflammatory drug-induced gastroduodenal injury in children. Arthritis Rheum 1995; 38: 1225-31.
17. LEN C, HILARIO MO, KAWAKAMI E et al.: Gastroduodenal lesions in children with juvenile rheumatoid arthritis. Hepatogastroenterology 1999; 46: 991-6.
18. BARRON KS, PERSON DA, BREWER EJ: The toxicity of nonsteroidal antiinflammatory drugs in juvenile rheumatoid arthritis. J Rheumatol 1982; 9: 149-55.
19. MULBERG AE, LINZ C, BERN E, TUCKER L, VERHAVE M, GRAND RJ: Identification of nonsteroidal antiinflammatory drug-induced gastroduodenal injury in children with juvenile rheumatoid arthritis. J Pediatrics 1993; 122: 647-9.
20. DRUMM B, RHOADS JM, STRINGER DA, SHERMAN PM, ELLIS LE, DURIE PR: Peptic ulcer disease in children: Etiology, clinical findings, and clinical course. Pediatrics 1988; 82: 410-4.
21. CHOUDHARY S, GIBSON PR, DEACON MC, YOUNG GP: Measurement of faecal alpha 1-antitrypsin: methodologies and clinical application. J Gastroenterol Hepatol 1996; 11: 311-8.
22. TIBBLE JA, SIGTHORSSON G, FOSTER R et al.: High prevalence of NSAID enteropathy as shown by a simple faecal test. Gut 1999; 45: 362-6.
23. PICCO P, GATTORNO M, MARCHESE N et al.: Increased gut permeability in juvenile chronic arthritides. A multivariante analysis of the diagnostic parameters. Clin Exp Rheumatol 2000; 18: 773-8.
24. ALAM AN, SARKER SA, WAHED MA, KHATUN M, RUHAMAN MM: Enteric protein loss and intestinal permeability changes in children during acute shigellosis and after recovery: Effect of zinc supplementation. Gut 1994; 35: 1707-11.
25. LIMA AA, SILVA TM, GIFONI AM et al.: Mucosal injury and disruption of intestinal barrier function in HIV-infected individuals with and without diarrhea and cryptosporidiosis in northeast Brazil. Am J Gastroenterol 1997; 92: 1861-6.
26. PIKE MG, RICHES P, ATHERTON DJ: Fecal alpha 1-antitrypsin concentration and gastrointestinal permeability to oligosaccharides in atopic dermatitis. Pediatr Dermatrol 1989; 6: 10-12.
27. VERA JF, GOTTELAND M, CHAVEZ E, VIAL MT, KAKARIEKA E, BRUNSER O: Sucrose permeability in children with gastric damage and Helicobacter pylori infection. J Pediatr Gastroenterol Nutri 1997; 24: 506-11.
28. SMECUOL E, BAI JC, SUGAI E et al.: Acute gastrointestinal permeability response to different non-steroidal anti-inflammatory drugs. Gut 2001; 49: 650-5.
29. ERLACHER L, WYATT J, PFLUGBEIL S et al.: Sucrose permeability as a marker for NSAID-induced gastroduodenal injury. Clin Exp Rheumatol 1998; 16: 69-71.
30. UIL JJ, ELBURG van RM, OVERBEEK van FM, MULDER CJJ, VANBERGE-HENEGOUWEN GP, HEYMANS HSA: Clinical implications of the sugar absorption test: intestinal permeability test to assess mucosal barrier function. Scand J Gastroenterol 1997; 32 (Suppl.): 70-8.
31. KURATA JH, NOGAWA AN: Meta-analysis of risk factors for peptic ulcer. J Clin Gastroenterol 1997; 24: 2-17.
32. CHAN FK, SUNG U, CHUNG SC et al.: Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers. Lancet 1997; 350: 975-9.
33. BIANCHI PORRO G, PARENTE F, IMBESI V, MONTRONE F, CARUSO I: Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in longterm NSAID users. Response to omeprazole dual therapy. Gut 1996; 39: 22-6.
34. DRUMM B, PEREZ-PEREZ GI, BLASER MJ, SHERMAN PM: Intra-familial clustering of Helicobacter pylori infection. N Engl J Med 1990; 322: 359-63.
35. CORVAGLIA L, BONTEMS P, DEVASTER JM: Accuracy of serology and 13C-urea breath test for detection of Helicobacter pylori in children. Pediatr Infect Dis J 1999; 18: 976-9.
36. RODRIGUEZ LAG, JICK H: Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994; 343: 769-72.
37. MOLLER HANSEN J, HALLAS J, LAURITSEN JM, BYTZER P: Non-steroidal anti-inflammatory drugs and ulcer complications: A risk factor analysis for clinical decision-making. Scand J Gastroenterol 1996; 31: 126-30.
38. RUSSELL RI: Defining patients at risk of non-steroidal anti-inflammatory drug gastropathy. Itl J Gastroenterol Hepatol 1999; 31 (Suppl. 1): S14-S18.